Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cardiology Review 6/3/2009. A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or.

Similar presentations


Presentation on theme: "Cardiology Review 6/3/2009. A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or."— Presentation transcript:

1 Cardiology Review 6/3/2009

2 A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or twice a year, but over the past 6 months, he has been experiencing them on a monthly basis. He reports that his heart starts racing suddenly for no reason, and the episode usually terminates abruptly after he takes a few deep breaths. Episodes typically last 10 to 15 minutes, although one episode last month lasted 30 minutes. He is otherwise healthy, denies other symptoms, and takes no medications. Results of his physical examination are within normal limits. A baseline EKG is obtained and shown. The ECHO demonstrated a subtle anterior wall motion abnormality but is otherwise WNL. A 24 hr holter demonstrates a narrow complex regular tachycardia with rate of 205 during an episode of palpitations. A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or twice a year, but over the past 6 months, he has been experiencing them on a monthly basis. He reports that his heart starts racing suddenly for no reason, and the episode usually terminates abruptly after he takes a few deep breaths. Episodes typically last 10 to 15 minutes, although one episode last month lasted 30 minutes. He is otherwise healthy, denies other symptoms, and takes no medications. Results of his physical examination are within normal limits. A baseline EKG is obtained and shown. The ECHO demonstrated a subtle anterior wall motion abnormality but is otherwise WNL. A 24 hr holter demonstrates a narrow complex regular tachycardia with rate of 205 during an episode of palpitations. What is the next step? RF ablation metoprolol stress test verapamil

3

4 A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or twice a year, but over the past 6 months, he has been experiencing them on a monthly basis. He reports that his heart starts racing suddenly for no reason, and the episode usually terminates abruptly after he takes a few deep breaths. Episodes typically last 10 to 15 minutes, although one episode last month lasted 30 minnutes. He is otherwise healthy, denies other symptoms, and takes no medications. Tesults of his physical examination are within normal limits. A baseline EKG is obtained and shown. The EKG demonstrated a subtle anterior wall motion abnormality but is otherwise WNL. A 24 hr holter demonstrates a narrow complex regular tachycardia with rate of 205 during an episode of palpitations. A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or twice a year, but over the past 6 months, he has been experiencing them on a monthly basis. He reports that his heart starts racing suddenly for no reason, and the episode usually terminates abruptly after he takes a few deep breaths. Episodes typically last 10 to 15 minutes, although one episode last month lasted 30 minnutes. He is otherwise healthy, denies other symptoms, and takes no medications. Tesults of his physical examination are within normal limits. A baseline EKG is obtained and shown. The EKG demonstrated a subtle anterior wall motion abnormality but is otherwise WNL. A 24 hr holter demonstrates a narrow complex regular tachycardia with rate of 205 during an episode of palpitations. What is the next step? RF ablation metoprolol stress test verapamilWPW

5 Short PR interval +delta wave +h/o tachycardia = WPW Short PR interval +delta wave +h/o tachycardia = WPW Two circuits: Two circuits: 1. AV node 2. retrograde accessory pathway QRS in narrow since there is conduction via AV node QRS in narrow since there is conduction via AV node The WMA is a result of abnormal depolarization via the accessory pathway. The WMA is a result of abnormal depolarization via the accessory pathway. RF ablation is first line RF ablation is first line Avoid metoprolol, CCB, and adenosine; they blocks the AV node but not the accessory. Avoid metoprolol, CCB, and adenosine; they blocks the AV node but not the accessory. Use Procainamide Use Procainamide WPW

6 A 45 yof is evaluated in the emergency department for palpitations. She has no history of CV disease but does have a h/o intermittent palpitations. This is her first prolonged episode, and cough and strain maneuvers that she has used in the past to terminate the episodes have been ineffective this time. PE is unremarkable with the exception of tachycardia. The BP is 110/70. EKG shown. A 45 yof is evaluated in the emergency department for palpitations. She has no history of CV disease but does have a h/o intermittent palpitations. This is her first prolonged episode, and cough and strain maneuvers that she has used in the past to terminate the episodes have been ineffective this time. PE is unremarkable with the exception of tachycardia. The BP is 110/70. EKG shown. What is the diagnosis: AV nodal reentrant tachycardia AV reentrant tachycardia ectopic atrial tachycardia multifocal atrial tachycardia a flutter

7

8 A 45 yof is evaluated in the emergency department for palpitations. She has no history of CV disease but does have a h/o intermittent palpitations. This is her first prolonged episdoe, and the cough and strain maneuvers that she has used in the past to terminate the episodes have been ineffective this time. PE is unremarkable with the exception of tachycardia. The BP is 110/70. EKG shown. A 45 yof is evaluated in the emergency department for palpitations. She has no history of CV disease but does have a h/o intermittent palpitations. This is her first prolonged episdoe, and the cough and strain maneuvers that she has used in the past to terminate the episodes have been ineffective this time. PE is unremarkable with the exception of tachycardia. The BP is 110/70. EKG shown. What is the diagnosis: AV nodal reentrant tachycardia AV reentrant tachycardia ectopic atrial tachycardia multifocal atrial tachycardia a flutter

9 Narrow complex tachycardia Narrow complex tachycardia No P waves; buried in the QRS complex No P waves; buried in the QRS complex Usual rate 160-180 Usual rate 160-180 Tx with IV adenosine Tx with IV adenosine Compare to: Compare to: AVRT- P waves are visible AVRT- P waves are visible MAT- irregular with 3 P wave morphologies. MAT- irregular with 3 P wave morphologies. AVNRT

10 AV Nodal Block 1 st degree: 1 st degree: prolonged PR prolonged PR Look for drug effect (dig, beta blocker, CCB) Look for drug effect (dig, beta blocker, CCB) 2 nd degree: 2 nd degree: Mobitz I: PR progressively lengthens, then a dropped beat Mobitz I: PR progressively lengthens, then a dropped beat Mobitz II: Intermittent non-conducted beats Mobitz II: Intermittent non-conducted beats 3 rd degree: complete dissociation 3 rd degree: complete dissociation PM: asymptomatic Mobitz II and complete block. PM: asymptomatic Mobitz II and complete block.

11 Torsades Atypical Vtach Atypical Vtach Look for hypoK or hypoMg Look for hypoK or hypoMg Worse prognosis than V tach Worse prognosis than V tach Management is different from other VTs Management is different from other VTs Avoid Class I, Ic or III antiarrhythmics (prolong QT) Avoid Class I, Ic or III antiarrhythmics (prolong QT) Give Magnesium acutely Give Magnesium acutely Things that cause torsades: arsenic, ciapride, droperidol, Li, methadone, fluoroquinolones Things that cause torsades: arsenic, ciapride, droperidol, Li, methadone, fluoroquinolones

12 A 79 yof is seen for an annual examination. She is in good health except for osteopenia, for which she takes Ca and VitD supplements. She walks regularly to and from the bus stop several times per week. It now takes her 25 min to get to the bus stop; whereas it only took her 10 min a year ago. She describes dyspnea midway in her walk, causing her to stop and catch her breath. She denies angina, presyncope, syncope or pedal edema. PE: HR 80, BP 165/86. Lungs CTAB, carotid upstrokes delayed. S1 nl, single S2, and S4. Grade 3/6 late peaking systolic murmur at R 2nd intercostal, radiates to R carotid. TTE with concentric LVH. EF 69%, no WMA. Trileaflet AV with heavy calcification, aortic jet 4.8/ m/sec, peak transaortic gradient of 92, valve area of 0.7 cm2. What will improve her quality of life? Begin ACEI Percutaneous aortic balloon valvuloplasty AVR Cardiac rehab Stop Calcium supplement

13

14 AS A 79 yof is seen for an annual examination. She is in good health except for osteopenia, for which she takes Ca and VitD supplements. She walks regularly to and from the bus stop several times per week. It takes her 25 mimn to get to the bus stop whereas it only took her 10 min a year ago. She describes dyspnea midway in her walk, causing her to stop and catch her breath. She denies angina, presyncope, syncope or pedal edema. PE: HR 80, BP 165/86. Lungs CTAB, carotid upstrokes delayed. S1 nl, single S2, and S4. Grade 3/6 late peaking systolic murmur at R 2nd intercostal, radiates to R carotid. TTE with concentric LVH. EF 69%, no WMA. Trileaflet AV with heavy calcification, aortic jet 4.8/ m/sec, peak transaortic gradient of 92, valve area of 0.7 cm2. What will improve quality of life? Begin ACEI Percutaneous aortic balloon valvuloplasty AVR Cardiac rehab Stop Calcium supplement

15 Severe AS: valve area below 0.8 Severe AS: valve area below 0.8 Most common cause: progressive valvular Ca Most common cause: progressive valvular Ca Initial compensatory mechanism is myocardial hypertrophy Initial compensatory mechanism is myocardial hypertrophy Indication for AVR: Indication for AVR: onset of cardiac symptoms onset of cardiac symptoms NOT prophylactically NOT prophylactically Triad of symptoms: Triad of symptoms: Angina Angina CHF CHF Syncope Syncope ACEIs contraindicated: afterload reduction may increase effective pressure gradient across stenotic valve. ACEIs contraindicated: afterload reduction may increase effective pressure gradient across stenotic valve. Aortic Stenosis

16 SoundsManeuversOther Mitral Stenosis Opening snap following S2 on LSB or apex. Middiastolic rumble. Loudest after exercise. RAD, negative biphasic P in V1 Mitral Regurg Holosystolic, blowing, over PMI, radiates to L axilla LAD, LVH, Aortic stenosis Harsh, crescendo/decrescendo, at R 2 nd intercostal Paradoxical splitting of S2, radiates to carotids with slow upstoke, louder with squatting or expiration. LVH Aortic regurg Faint, blowing between S2 and S1, diastolic, at LSB 3/4 th intercostal Wide pulse pressure, prominent carotid pulses. LVH VSD Holosystolic at LLSB Louder with handgrip ASD Fixed split S2 Primum: LAD, RBBB Secundum: RAD, RBBB Primum needs Abx prophy Primum may have AV block Murmurs

17 42 yof with recent onset of exertional dyspnea and occasional palpitations. She has been told for many years that she has a heart murmur. PE: BP 129/78 in both upper extremities, JVP elevated with both a and v waves. Apical pulse unremarkable. Parasternal impulse present. 2/6 midsystolic murmur noted at 2nd L intercostal and 2/6 holosystolic murmur at the apex and L sternal border. Fixes splitting of S2. 42 yof with recent onset of exertional dyspnea and occasional palpitations. She has been told for many years that she has a heart murmur. PE: BP 129/78 in both upper extremities, JVP elevated with both a and v waves. Apical pulse unremarkable. Parasternal impulse present. 2/6 midsystolic murmur noted at 2nd L intercostal and 2/6 holosystolic murmur at the apex and L sternal border. Fixes splitting of S2. Which is the most likely cause of the symptoms? secundum atrial septal defect primum atrial septal defect PFO sinus venosus atrial septal defect

18

19

20 ASD ASD 42 yof with recent onset of exertional dyspnea and occasional palpitations. She has been told for many years that she has a heart murmur. PE: BP 1269/78 in both upper extremities, JVP elevated with both a and v waves. Apical pulse unremarkable. Parasternal impulse present. 2/6 midsystilic murmur noted at 2nd L intercostal and 2/6 holosystolic murmur at the apex and L sternal border. Fixes splitting of S2. 42 yof with recent onset of exertional dyspnea and occasional palpitations. She has been told for many years that she has a heart murmur. PE: BP 1269/78 in both upper extremities, JVP elevated with both a and v waves. Apical pulse unremarkable. Parasternal impulse present. 2/6 midsystilic murmur noted at 2nd L intercostal and 2/6 holosystolic murmur at the apex and L sternal border. Fixes splitting of S2. Which is the most likely cause of the symptoms? secundum atrial septal defect primum atrial septal defect PFO sinus venosus atrial septal defect

21 Fixed splitting of S2: hallmark of ASD Fixed splitting of S2: hallmark of ASD Exam: Exam: Parasternal impulse: R sided cardiac enlargement (also seen on CXR) Parasternal impulse: R sided cardiac enlargement (also seen on CXR) Systolic murmur at the apex: mitral regurg Systolic murmur at the apex: mitral regurg L sternal border: TVR L sternal border: TVR midsystolic murmur: flow across the pulmonary valve. midsystolic murmur: flow across the pulmonary valve. EKG shows first degree AV vlock and LAD= primum EKG shows first degree AV vlock and LAD= primum PE for PFO is normal PE for PFO is normal Why does this matter: Secundum and PFO can be treated with percutaneous devices. Why does this matter: Secundum and PFO can be treated with percutaneous devices. ASD

22 69 yom is evaluated in the ED for acute onset of substernal CP radiating to the L arm. Former smoker and PMH of HTN. PE 210/95 R arm, 164/56 L arm, HR 90, RR 20, dullness half way up the R posterior thorax, 2/6 diastolic murmur at RUSB, EKG with NSR, 2-3 mm inferior ST segment elevation. 69 yom is evaluated in the ED for acute onset of substernal CP radiating to the L arm. Former smoker and PMH of HTN. PE 210/95 R arm, 164/56 L arm, HR 90, RR 20, dullness half way up the R posterior thorax, 2/6 diastolic murmur at RUSB, EKG with NSR, 2-3 mm inferior ST segment elevation. What is the most appropriate med to administer? ASA IV heparin Thrombolytic Beta blocker ACEI

23 Dissection 69 yom is evaluated in the ED for acute onset of substernal CP radiating to the L arm. Former smoker and PMH of HTN. PE 210/95 R arm, 164/56 L arm, HR 90, RR 20, dullness half way up the R posterior thorax, 2/6 diastolic murmur at RUSB, EKG with NSR, 2-3 mm inferior ST segment elevation. 69 yom is evaluated in the ED for acute onset of substernal CP radiating to the L arm. Former smoker and PMH of HTN. PE 210/95 R arm, 164/56 L arm, HR 90, RR 20, dullness half way up the R posterior thorax, 2/6 diastolic murmur at RUSB, EKG with NSR, 2-3 mm inferior ST segment elevation. What is the most appropriate med to administer? ASA IV heparin Thrombolytic Beta Blocker ACEI

24 Disparate blood pressures + diastolic murmur of AR Disparate blood pressures + diastolic murmur of AR = acute ascending aortic dissection (involves the AV) Dullness in R lung = hemothorax (complication of dissection) Dullness in R lung = hemothorax (complication of dissection) RCA is the most common involved coronary with dissection, ischemia (STEMI). RCA is the most common involved coronary with dissection, ischemia (STEMI). Initial Treatment Initial Treatment beta blockade (decrease shear stress) beta blockade (decrease shear stress) Start BB before afterload reduction. Start BB before afterload reduction. Avoid: ASA, heparin, thrombolytics Avoid: ASA, heparin, thrombolytics Increased risk of: periaortic hemorrhage, aortic rupture, and cardiac tamponade Increased risk of: periaortic hemorrhage, aortic rupture, and cardiac tamponade Studies: TEE, chest CT with contrast, contrasted MR. Studies: TEE, chest CT with contrast, contrasted MR. Aortic Dissection

25 A 68 yom is evaluated in the ED for chest pain that has lasted 90 min. He was eating when he developed sudden onset of sharp precordial pain radiating toward both shoulders and back. The pain is 9/10. PMH for HTN and dyslipidemia. PE: HR 90, RR 19 BP 110/60, O2 sat 94% on RA. Lungs: bibasilar crackles. Heart sounds distant, nl S1, S2, no S4 or S3. 3/6 diastolic murmur at the RUSB, radiates across L precordium. No abdominal bruits. Trace pedal edema. P CXR with prominent thoracic aorta and widening of the mediastinum. A 68 yom is evaluated in the ED for chest pain that has lasted 90 min. He was eating when he developed sudden onset of sharp precordial pain radiating toward both shoulders and back. The pain is 9/10. PMH for HTN and dyslipidemia. PE: HR 90, RR 19 BP 110/60, O2 sat 94% on RA. Lungs: bibasilar crackles. Heart sounds distant, nl S1, S2, no S4 or S3. 3/6 diastolic murmur at the RUSB, radiates across L precordium. No abdominal bruits. Trace pedal edema. P CXR with prominent thoracic aorta and widening of the mediastinum. Next step? cath fibrinolytic therapy VQ scan CT chest balloon pump

26

27 Aortic dissection with AR A 68 yom is evaluated in the ED for chest pain that has lasted 90 min. He was eating when he developed sudden onset of sharp precordial pain radiating toward both shoulders and back. The pain is 9/10. PMH for HTN and dyslipidemia. PE: HR 90, RR 19 BP 110/60, O2 sat 94% on RA. Lungs: bibasilar crackles. Heart sounds distant, nl S1, S2, no S4 or S3. 3/6 diastolic murmur at the RUSB, radiates across L precordium. No abdominal bruits. Trace pedal edema. P CXR with prominent thoracic aorta and widening of the mediastinum. A 68 yom is evaluated in the ED for chest pain that has lasted 90 min. He was eating when he developed sudden onset of sharp precordial pain radiating toward both shoulders and back. The pain is 9/10. PMH for HTN and dyslipidemia. PE: HR 90, RR 19 BP 110/60, O2 sat 94% on RA. Lungs: bibasilar crackles. Heart sounds distant, nl S1, S2, no S4 or S3. 3/6 diastolic murmur at the RUSB, radiates across L precordium. No abdominal bruits. Trace pedal edema. P CXR with prominent thoracic aorta and widening of the mediastinum. Next step? cath fibrinolytic therapy VQ scan CT chest balloon pump – This would exacerbate the acute AR

28 Aortic Regurg: Diastolic murmur Aortic Regurg: Diastolic murmur Risk Factors: Risk Factors: age age HTN HTN bicuspid aortic valve bicuspid aortic valve Coarctations Coarctations 3 rd trimester pregnancy and Marfans) 3 rd trimester pregnancy and Marfans) Possible imaging include: Possible imaging include: CT chest with contrast CT chest with contrast MRI with contrast MRI with contrast TEE TEE Complications: Complications: MI from anterograde propogation, MI from anterograde propogation, Tamponade Tamponade limb ischemia (if great vessels involved) limb ischemia (if great vessels involved) aortic rupture aortic rupture Ascending Dissection with Acute AR

29 Ascending vs Descending Ascending dissections are high risk for complications. Do not pass go, instead… go directly to surgery. Descending dissections treat medically (Beta Blockers and nitroprusside-if needed), and if pain persists, it is due to extension of dissection, then go to surgery. Even with repair mortality is 26%, without 55%

30 AAA Screen all men with smoking hx after age 65 (medicare pays for this) Screen all men with smoking hx after age 65 (medicare pays for this) AAA, DM are both CAD equivalents AAA, DM are both CAD equivalents Surgery Surgery Men >5 cm Men >5 cm Women >4.5 Women >4.5 Marfans >4.5 Marfans >4.5 expands more than 0.5/year expands more than 0.5/year

31 64 yof presents 6 hrs after onset of severe crushing chest pain associated with diaphoresis, n/v. She has a h/o mild hyperlipidemia, meds include atorvastatin and ASA. BP 140/88, HR 88, lungs clear, no murmurs, abd and extremities normal. EKG 3 mm ST elevation in leads II, III, and aVF, occasional PVCs. No cath lab facilities are present, fibrinolytics are given and transferred to ICU. CP resolves. 2 episodes of 6-10 beats of Vtach noted with stable hemodynamics. EKG now shows <0.5 mV ST segment elevation. 64 yof presents 6 hrs after onset of severe crushing chest pain associated with diaphoresis, n/v. She has a h/o mild hyperlipidemia, meds include atorvastatin and ASA. BP 140/88, HR 88, lungs clear, no murmurs, abd and extremities normal. EKG 3 mm ST elevation in leads II, III, and aVF, occasional PVCs. No cath lab facilities are present, fibrinolytics are given and transferred to ICU. CP resolves. 2 episodes of 6-10 beats of Vtach noted with stable hemodynamics. EKG now shows <0.5 mV ST segment elevation. In addition to heparin ans ASA, which is the next appropriate step? CathPlavix Beta blocker amiodaroneDSE

32 64 yow presents 6 hrs after onset of severe crushing chest pain associated with diaphoresis, n/v. She has a h/o mild hyperlipidemia, meds in clude atorvastatin and ASA. BP 140/88, HR 88, lungs clear, no murmurs, abd and extremities normal. EKG 3 mm ST elevation in leads II, III, and aVF, occasional PVCs. No cath lab facilities are present, fibrinolytics are given and transferred to ICU. CP resolves. 2 episodes of 6-10 beats of Vtaqch noted with stable hemodynamics. EKG now shows <0.5 mV ST segment elevation. 64 yow presents 6 hrs after onset of severe crushing chest pain associated with diaphoresis, n/v. She has a h/o mild hyperlipidemia, meds in clude atorvastatin and ASA. BP 140/88, HR 88, lungs clear, no murmurs, abd and extremities normal. EKG 3 mm ST elevation in leads II, III, and aVF, occasional PVCs. No cath lab facilities are present, fibrinolytics are given and transferred to ICU. CP resolves. 2 episodes of 6-10 beats of Vtaqch noted with stable hemodynamics. EKG now shows <0.5 mV ST segment elevation. In addition to heparin ans ASA, which is the next appropriate step? CathPlavix Beta blocker amiodaroneDSE

33 Medical management After MI: Medical management After MI: ASA ASA beta blockers beta blockers ACEI ACEI Statin Statin Reperfusion arrhythmias usu do not require additional antiarrhythmic therapy. Reperfusion arrhythmias usu do not require additional antiarrhythmic therapy. Immediate cath after STEMI for: Immediate cath after STEMI for: recurrent ischemia recurrent ischemia persistent ST elevation persistent ST elevation hemodynamic instability hemodynamic instability CHF CHF Inferior STEMI

34 ACS Treatment for the Boards ASA ASA Plavix (with, or prior to, PCI- CURE trial), Plavix (with, or prior to, PCI- CURE trial), Lovenox (more effective than heparin) Lovenox (more effective than heparin) beta blocker beta blocker ACEI ACEI IIbIIIa for PCI but NOT without PCI IIbIIIa for PCI but NOT without PCI Statin Statin smoking cessation. smoking cessation.

35 78 yom brought to the ED for malaise, fatigue and mild dyspnea on exertion. Intermittent CP for 5 days, with the most severe episode 2 days ago. Pain free since then. PMH: HTN, DM type 2, meds: ACEI and metformin. BP 112/82, HR 92, JVP is 5 mmHg, no carotid bruits, lungs clear. CV nl S1/S2, 2/6 holosystoloic murmur at apex to axilla, diminished leg pulses, no edema. EKG with sinus tach, Q waves in V1-4. Renal fn and Hct are normal. CK 120, Troponin 6.8. CXR with mild pulmonary edema. Pt is started on lovenox and ASA. Next appropriate therapeutic approach is? plavix glycoprotein receptor blocker fibrinolysis urgent cath beta blocker

36 Anterior STEMI 78 yom brought to the ED for malaise, fatigue and mild dyspnea on exertion. Intermittent Cp for 5 days, most severe episode 2 days ago. Pain free since then. PMH: HTN, DM type 2, meds: ACEI and metformin. BP 112/82, HR 92, JVP is 5 mmHg, no carotid bruits, lungs clear. CV nl S1/S2, 2/6 holosystoloic murmur at apex to axilla, diminished leg pulses, no edema. EKG with sinus tach, Q waves in V1-4. Renal fn and Hct are normal. CK 120, Troponin 6.8. CXR with mild pulmonary edema. Pt is started on lovenox and ASA. Next appropriate therapeutic approach is? plavix glycoprotein receptor blocker fibrinolysis urgent cath beta blocker

37 Beta Blockers are always a good answer. Beta Blockers are always a good answer. Unless signs of persistent ischemia, cath is not urgently indicated. Unless signs of persistent ischemia, cath is not urgently indicated. Late fibrinolysis not beneficial, and increases risk of hemorrhage in the infarcted zone. Late fibrinolysis not beneficial, and increases risk of hemorrhage in the infarcted zone. No benefit of plavix added to ASA if there are no plans on PCI No benefit of plavix added to ASA if there are no plans on PCI IIbIIIa is indicated for patients who are going to cath/PCI, if there are high risk factors such as: IIbIIIa is indicated for patients who are going to cath/PCI, if there are high risk factors such as: TIMI>3 TIMI>3 elevated troponin elevated troponin ongoing ischemia ongoing ischemia new ST changes new ST changes CHF or DM CHF or DM hemodynamic instability hemodynamic instability PCI within the past 6 months PCI within the past 6 months Anterior STEMI

38 42 yom evaluated in Halifax Regional for L shoulder chest pain that radiates to the jaw, associated with diaphoresis and mild dyspnea. No PMH, no meds. FH of CAD in first degree relatives. ED administered IV heparin, atenolol, ASA. BP 100/79, HR 61, no JVD, no carotid bruits, lungs clear, nl S1/S2, no murmurs. Abd and extremities wnl. No cath lab at the OSH, UNC is 62 miles away, and will take 2 hours. 42 yom evaluated in Halifax Regional for L shoulder chest pain that radiates to the jaw, associated with diaphoresis and mild dyspnea. No PMH, no meds. FH of CAD in first degree relatives. ED administered IV heparin, atenolol, ASA. BP 100/79, HR 61, no JVD, no carotid bruits, lungs clear, nl S1/S2, no murmurs. Abd and extremities wnl. No cath lab at the OSH, UNC is 62 miles away, and will take 2 hours. Before transfer you should give….. 2b3a receptor blocker plavixesmolol fibrinolytic therapy NTG

39

40 STEMI with no Cath Lab STEMI with no Cath Lab 42 yom evaluated in rural ED for L shoulder chest pain that radiates to the jaw, associated with diaphoresis and mild dyspnea. No PMH, no meds. FH of CAD in first degree relatives. ED administered IV heparin, atenolol, ASA. BP 100/79, HR 61, no JVD, no carotid bruits, lungs clear, nl S1/S2, no murmurs. Abd and extremities wnl. No cath lab at the OSH, UNC is 62 miles away, and will take 2 hours. 42 yom evaluated in rural ED for L shoulder chest pain that radiates to the jaw, associated with diaphoresis and mild dyspnea. No PMH, no meds. FH of CAD in first degree relatives. ED administered IV heparin, atenolol, ASA. BP 100/79, HR 61, no JVD, no carotid bruits, lungs clear, nl S1/S2, no murmurs. Abd and extremities wnl. No cath lab at the OSH, UNC is 62 miles away, and will take 2 hours. Before transfer you should give….. 2b3a receptor blocker plavixesmolol fibrinolytic therapy NTG

41 The best answer is always CATH The best answer is always CATH Second best is FIBRINOLYSIS Second best is FIBRINOLYSIS Fibrinolysis Fibrinolysis Given within 30 minutes of arrival to ED Given within 30 minutes of arrival to ED DO NOT give if >12 hours after onset of symptoms and asymptomatic (this pt is less than 12 hours) DO NOT give if >12 hours after onset of symptoms and asymptomatic (this pt is less than 12 hours) Contraindications: Contraindications: recent surgery recent surgery CVA CVA Bleeding Bleeding uncontrolled HTN uncontrolled HTN PUD PUD cardiogenic shock cardiogenic shock STEMI and Fibrinolytics

42 68 yom seen 14 hrs after onset of substernal CP that lasted for 2 hrs. 6 hrs prior to presentation he experienced 2 additional shorter episodes of CP, each 10 min in duration. CP associated with diaphoresis, no dyspnea, palpitations, or dizziness. H/o HTN, DM, active smoker 40 pack year hx. Home meds: ASA, norvasc, metoprolol and glyburide. PE: normotensive, NAD, enlarged PMI. CK and troponins elevated, EKG with small R waves in V1-3, unchanged by day 3 of hospitalization. ECHO with severe hypokinetic LV anterior wall, moderate hypokinesis of the inferior wall and LVEF 38%. Current meds: metoprolol, asa, NTG, plavix, lipitor, lisinopril, heparin. What is the most appropriate evaluation prior to discharge? 24 hr EKG low level treadmill stress test dobutamine viability study cath

43 68 yom seen 14 hrs after onset of substernal CP that lasted for 2 hrs. 6 hrs prior to presentation he experienced 2 additional shorter episodes of CP, each 10 min in duration. CP associated with diaphoresis, no dyspnea, palpitations, or dizziness. H/o HTN, DM, active smoker 40 pack year hx. Home meds: ASA, norvasc, metoprolol and glyburide. PE: normotensive, NAD, enlarged PMI. CK and troponins elevated, EKG with small R waves in V1-3, unchanged by day 3 of hospitalization. ECHO with severe hypokinetic LV anterior wall, moderate hypokinesis of the inferior wall and LVEF 38%. Current meds: metoprolol, asa, NTG, plavix, lipitor, lisinopril, heparin. What is the most appropriate evaluation prior to discharge? 24 hr EKG low level treadmill stress test dobutamine viability study cath

44 Patient did not get revascularization or thrombolytics. By ECHO pt has decreased EF and 2 areas of WMA with TIMI 5 Patient did not get revascularization or thrombolytics. By ECHO pt has decreased EF and 2 areas of WMA with TIMI 5 High risk factors for complications after MI: High risk factors for complications after MI: Multivessel CAD Multivessel CAD anterior MI anterior MI EF <40% EF <40% CHF CHF recurrent ischemia recurrent ischemia Never subject a high risk pt to stress testing even if submaximal stress. Never subject a high risk pt to stress testing even if submaximal stress. >12 Hours out from an Anterior MI

45 Post-MI complications 1.Recurrent ischemia: 1/3 of patients, and more common in NSTEMI rather than STEMI. 2.Arrhythmias: bradycardia, SVT/atrial fibrillation, ventricular arrhythmias (mostly in the first few hours), AV block, 3.CHF 4.Myocardial rupture: rupture of the LV, 1% of pts, 2-7 days (pseudoaneurysm- rupture sealed by pericardium) 5.LV aneursym: from scar, predisposed to CHF, thrombus, and arrhythmias 6.Papillary muscle rupture: posteromedial papillary muscle is more common b/c single blood supply from RCA. Classic case: inferior MI, later becomes hypotensive, large V waves in PA wedge tracing, new holosytolic murmur at the apex. 7.Mural thrombi (in anterior and apical STEMI) 8.pericarditis

46 45 yom brought by EMS for severe CP. Pain similar to prior episode when he underwent angioplasty 8 m ago. H/O HTN, on beta blocker, also takes ASA 81 mg q day. Nl serum CH and no h/o DM, DOE or claudication. PE: BP 90/60, HR 59, no JVD, no bruits, lungs clear, Nl S1, S2. S4 present with 1/6 SEM at LSB, nonradiating. Abd and extremities nl. EKG with ST depression in II, III, and aVF. Admitted and placed on plavix, nitrates, and lovenox. Troponin 0.8 (nl <0.5). What is the next appropriate step? HeparinesmololabciximabNTG

47 USA 45 yom brought by EMS for severe CP. Pain similar to prior episode when he underwent angioplasty 8 m ago. H/O HTN, on beta blocker, also takes ASA 81 mg q day. Nl serum CH and no h/o DM, DOE or claudication. PE: BP 90/60, HR 59, no JVD, no bruits, lungs clear, Nl S1, S2. S4 present with 1/6 SEM at LSB, nonradiating. Abd and extremities nl. EKG with ST depression in II, III, and aVF. Admitted and placed on plavix, nitrates, and lovenox. Troponin 0.8 (nl <0.5). What is the next appropriate step? HeparinesmololabciximabNTG

48 IIbIIIa: IIbIIIa: beneficial with pts going to PCI beneficial with pts going to PCI associated with increased mortality for those not going to PCI associated with increased mortality for those not going to PCI Who should get it: Who should get it: TIMI >3 TIMI >3 recurrent angina recurrent angina elevated troponin elevated troponin new ST depressions new ST depressions prior CABG prior CABG percutaneous intervention within 6 months percutaneous intervention within 6 months VTach VTach hemodynamic instability hemodynamic instability Plavix is also indicated, but usually held if going to cath in case CABG needed. Plavix is also indicated, but usually held if going to cath in case CABG needed. USA and NSTEMI

49 49 yom presents to the ED with mild chest discomfort, with nausea and dyspnea for 2 hours. No relief with antacids. No PMH, no meds. Older brother with an MI 9 months earlier, father with CABG 12 years ago. BP 109/78, HR 88, no jvd, no carotid bruits, nl S1/S2, no m/r/g, lungs, abd, extremities wnl. Troponin of 6. EKG with 1mV ST elevation in II, III and aVF. Started on lovenox, asa, metoprolol, and IIbIIIa, and sent to cath. DES placed in subtotally occluded RCA. ECHO on d#2 shows nl LV, no MR, no effusion. D#4 no complications, and plan on d/c. 49 yom presents to the ED with mild chest discomfort, with nausea and dyspnea for 2 hours. No relief with antacids. No PMH, no meds. Older brother with an MI 9 months earlier, father with CABG 12 years ago. BP 109/78, HR 88, no jvd, no carotid bruits, nl S1/S2, no m/r/g, lungs, abd, extremities wnl. Troponin of 6. EKG with 1mV ST elevation in II, III and aVF. Started on lovenox, asa, metoprolol, and IIbIIIa, and sent to cath. DES placed in subtotally occluded RCA. ECHO on d#2 shows nl LV, no MR, no effusion. D#4 no complications, and plan on d/c. In addition to ASA, plavix, and metoprolol what should be given? Lipitorlisinoprilwarfarinniacin

50 49 yom presents to the ED with mild chest discomfort, with nausea and dyspnea for 2 hours. No relief with antacids. No PMH, no meds. Older brother with an MI 9 months earlier, father with CABG 12 years ago. BP 109/78, HR 88, no jvd, no carotid bruits, nl S1/S2, no m/r/g, lungs, abd, extremities wnl. Troponin of 6. EKG with 1mV ST elevation in II, III and aVF. Started on lovenox, asa, metoprolol, and IIbIIIa, and sent to cath. DES placed in subtotally occluded RCA. ECHO on d#2 shows nl LV, no MR, no effusion. D#4 no complications, and plan on d/c. 49 yom presents to the ED with mild chest discomfort, with nausea and dyspnea for 2 hours. No relief with antacids. No PMH, no meds. Older brother with an MI 9 months earlier, father with CABG 12 years ago. BP 109/78, HR 88, no jvd, no carotid bruits, nl S1/S2, no m/r/g, lungs, abd, extremities wnl. Troponin of 6. EKG with 1mV ST elevation in II, III and aVF. Started on lovenox, asa, metoprolol, and IIbIIIa, and sent to cath. DES placed in subtotally occluded RCA. ECHO on d#2 shows nl LV, no MR, no effusion. D#4 no complications, and plan on d/c. In addition to ASA, plavix, and metoprolol what should be given? Lipitorlisinoprilwarfarinniacin

51 Statins are given regardless of cholesterol level after MI because they reduce late CV events. Statins are given regardless of cholesterol level after MI because they reduce late CV events. PROVE-IT TIMI 22: showed high dose atorvastatin 80 was superior to pravastatin 40 with a 16% reduction of a composite endpoint. PROVE-IT TIMI 22: showed high dose atorvastatin 80 was superior to pravastatin 40 with a 16% reduction of a composite endpoint.

52 Dyslipidemia Develop more side effects on statins when you are concurrently on fibrates or niacin. Develop more side effects on statins when you are concurrently on fibrates or niacin. Goals: ATP III-R 2005 Goals: ATP III-R 2005 RF: tobacco, HTN, Family history, AGE (men>45, women >55) RF: tobacco, HTN, Family history, AGE (men>45, women >55) LDL goal NonHDL goal CAD or equivele nt (DM) <70<130 2+ RF <100<160 0-1 RF <130<190

53 23 yof is brought to the ED after a witnessed syncopal event. The patient reports having been at church where she DFO, after standing for 45 minutes. She noted feeling sweaty and lightheaded and seeing spots. She was aware of the sensation of her heart beating and then developed LOC. After the fall, witnessed said she had a thready pulse and urinary incontinence. She regained consciousness within 3 minutes. Which of the following aspects of the hx is not consistent with neurocardiogenic syncope? Urinary incontinence Prodrome of seeing spots, diaphoresis and lightheadedness Thready pulse None of the above

54 23 yof is brought to the ED after a witnessed syncopal event. The patient reports having been at church where she DFO, after standing for 45 minutes. She noted feeling sweaty and lightheaded and seeing spots. She was aware of the sensation of her heart beating and then developed LOC. After the fall, witnessed said she had a thready pulse and urinary incontinence. She regained consciousness within 3 minutes. Which of the following aspects of the hx is not consistent with neurocardiogenic syncope? Urinary incontinence Prodrome of seeing spots, diaphoresis and lightheadedness Thready pulse None of the above

55 Neurocardiogenic syncope vasovagal and vasodepressor: vasovagal and vasodepressor: Lose of sympathetic tone with vasodilation. Lose of sympathetic tone with vasodilation. with vasovagal there is bradycardia (due to increased vagal tone) with vasovagal there is bradycardia (due to increased vagal tone) Look for situational stressors: hot, crowded spaces, stressful environment, long period of standing, hunger, pain. Look for situational stressors: hot, crowded spaces, stressful environment, long period of standing, hunger, pain. Prodrome: Prodrome: light-headedness light-headedness Diaphoresis Diaphoresis Nausea Nausea Weakness Weakness visual changes visual changes pallor pallor Incontinence suggests seizure Incontinence suggests seizure

56 Cardiogenic syncope Arrhythmia: Bradyarrhythmia, ventricular arrhythmia or V fib, AV node block Arrhythmia: Bradyarrhythmia, ventricular arrhythmia or V fib, AV node block Mechanical: Aortic valve (AS) or HOCM Mechanical: Aortic valve (AS) or HOCM Absence of premonitory symptoms, usually exertional Absence of premonitory symptoms, usually exertional Quick recovery Quick recovery

57 Orthostatic syncope 1 st - Dehydration 1 st - Dehydration 2 nd - polypharmacy 2 nd - polypharmacy AV nodal blockade (BB, CCB) AV nodal blockade (BB, CCB) Anticholinergics Anticholinergics 3 rd - autonomic insufficiency- DM 3 rd - autonomic insufficiency- DM

58 HTN-JNC7 Treatment of HTN benefits are greater in the older patients compared to young patients. Reduces CVA, CHF and CV events, but not overall mortality Treatment of HTN benefits are greater in the older patients compared to young patients. Reduces CVA, CHF and CV events, but not overall mortality Isolated systolic HTN is still high risk, even in the elderly, and should be treated. Isolated systolic HTN is still high risk, even in the elderly, and should be treated. Wide pulse pressure is a risk factor for CHF. Wide pulse pressure is a risk factor for CHF. All patients: All patients: weight loss weight loss stop EtOH, stop EtOH, limit Na, limit Na, exercise exercise

59 HTN-JNC 7 Stage 1: 140-159/90-99 Stage 1: 140-159/90-99 Stage II: >160/100 Stage II: >160/100 Goal: treat to < 140/90 or <130/80 if DM Goal: treat to < 140/90 or <130/80 if DM Always start with a thiazide unless Post MI or CKD Always start with a thiazide unless Post MI or CKD The number one reason for failure to control hypertension despite multiple agents is the failure to use a thiazide diuretic. The number one reason for failure to control hypertension despite multiple agents is the failure to use a thiazide diuretic. 1. CHF: thiazide, BB, ACEI, ARB, spironolactone 2. POST MI: BB, ACEI, spironolactone 3. DM: thiazide, BB< ACEI, ARB, CCB 4. CKD: ACEI, ARB 5. Recurrent CVA: thiazide, ACEI 6. High CVD risk: thiazide, BB, ACEI, CCB


Download ppt "Cardiology Review 6/3/2009. A 28 yom is evaluated for palpitations. He reports a 5 year history of palpitations. These episodes used to occur once or."

Similar presentations


Ads by Google